Review
doi: 10.2214/AJR.10.6002.Benign biliary strictures: a current comprehensive clinical and imaging review
Affiliations
- PMID:21785056
- DOI: 10.2214/AJR.10.6002
Item in Clipboard
Review
Benign biliary strictures: a current comprehensive clinical and imaging review
Alampady Krishna Prasad Shanbhogue et al. AJR Am J Roentgenol.2011 Aug.
Display options
Format
Display options
Format
Abstract
Objective: There is a wide spectrum of nonneoplastic causes of biliary stricture that can pose a significant challenge to clinicians and radiologists. Imaging plays a key role in differentiating benign from malignant strictures, defining the extent, and directing the biopsy. We describe the salient clinical and imaging manifestations of benign biliary strictures that will help radiologists to accurately diagnose these entities.
Conclusion: Accurate diagnosis and management are based on correlating imaging findings with epidemiologic, clinical, and laboratory data. Cross-sectional imaging modalities permit precise localization of the site and length of the segment involved, thereby serving as a road map to surgery, and permit exclusion of underlying malignancy.
Similar articles
- Contrast-enhanced MRI combined with MR cholangiopancreatography for the evaluation of patients with biliary strictures: differentiation of malignant from benign bile duct strictures.Kim JY, Lee JM, Han JK, Kim SH, Lee JY, Choi JY, Kim SJ, Kim HJ, Kim KH, Choi BI.Kim JY, et al.J Magn Reson Imaging. 2007 Aug;26(2):304-12. doi: 10.1002/jmri.20973.J Magn Reson Imaging. 2007.PMID:17623893
- Imaging of biliary tract inflammation: an update.Knowlton JQ, Taylor AJ, Reichelderfer M, Stang J.Knowlton JQ, et al.AJR Am J Roentgenol. 2008 Apr;190(4):984-92. doi: 10.2214/AJR.07.3033.AJR Am J Roentgenol. 2008.PMID:18356446Review.
- HIV-related/AIDS cholangiopathy: pictorial review with emphasis on MRCP findings and differential diagnosis.Tonolini M, Bianco R.Tonolini M, et al.Clin Imaging. 2013 Mar-Apr;37(2):219-26. doi: 10.1016/j.clinimag.2012.03.008. Epub 2012 Jun 8.Clin Imaging. 2013.PMID:23465971Review.
- Differentiating benign from malignant idiopathic biliary strictures: are we there yet?Larghi A, Waxman I.Larghi A, et al.Gastrointest Endosc. 2007 Jul;66(1):97-9. doi: 10.1016/j.gie.2006.12.047.Gastrointest Endosc. 2007.PMID:17591480No abstract available.
- Spectrum of benign lesions mimicking a malignant stricture at the liver hilum.Kassahun WT, Jonas S.Kassahun WT, et al.Rev Recent Clin Trials. 2009 Sep;4(3):185-94. doi: 10.2174/157488709789957547.Rev Recent Clin Trials. 2009.PMID:20028331Review.
Cited by
- Percutaneous Management of Benign Biliary Strictures.Fang A, Kim IK, Ukeh I, Etezadi V, Kim HS.Fang A, et al.Semin Intervent Radiol. 2021 Aug;38(3):291-299. doi: 10.1055/s-0041-1731087. Epub 2021 Aug 10.Semin Intervent Radiol. 2021.PMID:34393339Free PMC article.Review.
- Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1.Dumonceau JM, Delhaye M, Charette N, Farina A.Dumonceau JM, et al.Therap Adv Gastroenterol. 2020 Jun 16;13:1756284820927292. doi: 10.1177/1756284820927292. eCollection 2020.Therap Adv Gastroenterol. 2020.PMID:32595761Free PMC article.Review.
- [Metformin inhibits collagen production in rat biliary fibroblasts: the molecular signaling mechanism].Lu J, Zhang J, Lü Y, Wang B, Jia L, Shi J.Lu J, et al.Nan Fang Yi Ke Da Xue Xue Bao. 2020 May 30;40(5):640-646. doi: 10.12122/j.issn.1673-4254.2020.05.05.Nan Fang Yi Ke Da Xue Xue Bao. 2020.PMID:32897197Free PMC article.Chinese.
- Diagnosis of Malignant Biliary Strictures: Conventional or Negative Pressure Brush Cytology?Abbasi MR, Ghazi Mirsaeed SM, Mohammad Alizadeh AH.Abbasi MR, et al.Asian Pac J Cancer Prev. 2016 Oct 1;17(10):4563-4566. doi: 10.22034/apjcp.2016.17.10.4563.Asian Pac J Cancer Prev. 2016.PMID:27892663Free PMC article.
- Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach.Urman JM, Herranz JM, Uriarte I, Rullán M, Oyón D, González B, Fernandez-Urién I, Carrascosa J, Bolado F, Zabalza L, Arechederra M, Alvarez-Sola G, Colyn L, Latasa MU, Puchades-Carrasco L, Pineda-Lucena A, Iraburu MJ, Iruarrizaga-Lejarreta M, Alonso C, Sangro B, Purroy A, Gil I, Carmona L, Cubero FJ, Martínez-Chantar ML, Banales JM, Romero MR, Macias RIR, Monte MJ, Marín JJG, Vila JJ, Corrales FJ, Berasain C, Fernández-Barrena MG, Avila MA.Urman JM, et al.Cancers (Basel). 2020 Jun 21;12(6):1644. doi: 10.3390/cancers12061644.Cancers (Basel). 2020.PMID:32575903Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical